Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale

Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round of investment is also participated by Elev8, Seed Capitals, and other existing shareholders.

East Ventures’ portfolio companies listed amongst Tech in Asia’s 50 rising startups in Indonesia

Which startups are on the path to becoming the next big thing? One way to tell would be to check when they’ve raised a new round. Tech in Asia has generated a list of startups in Indonesia that have recently raised funding.

Tracking progress: How companies can reduce their carbon footprint

The 2015 Paris Agreement marked a paradigm shift surrounding climate change – a transition from individual to corporate responsibility. Before this accord, “carbon footprint generally referred to personal emissions. Now, however, corporations are held accountable for their greenhouse gas (GHG) emissions.

East Ventures consistently races in the perfect storm: 2023 recap & 2024 outlook

The tech industry weathered an intense “perfect storm” of crises these past two years. The global economy is in a complex state characterized by uncertainty, making caution our guiding principle. We find ourselves in a landscape where valuations are far from their peak, the global economy remains sluggish, inflationary pressures persist, and the threat of a potential global recession looms large.

Investing in Southeast Asia’s digital ecosystem: Interview with East Ventures’ Partners

Southeast Asia is resilient in a global tech landscape marked by turbulence, showcasing distinctive strengths amidst adversity. As a pioneering and leading sector-agnostic venture capital (VC) firm, East Ventures remains committed to fostering and investing in Southeast Asia’s digital ecosystem.

Buoyant life sciences sector emerges stronger

As we bid farewell to another eventful year in the world of life sciences, it's time to look back at the whirlwind of advancements and changes that have shaped the industry in 2023. Back in January this year, we interacted with leaders from various market segments who shared their insights into what the year held for their particular spheres. Let's recap the 2023 predictions and find out if they panned out as predicted.